Pot Stocks Shoot Higher as Analyst Raises Canopy Growth Target by 50%

By CCN.com: Piper Jaffray has raised its price target on Canopy Growth shares from $ 40 to $ 60, sending Canopy and other cannabis-related stocks upwards. The analyst says Canopy Growth’s step into the US makes them “bullish” on the potential of the stock. The cannabis company’s shares have already surged nearly 10% today, and other so-called

The post Pot Stocks Shoot Higher as Analyst Raises Canopy Growth Target by 50% appeared first on CCN

News – CCN

China’s Stocks Are on Fire Despite Slowest GDP Growth in Nearly 30 Years

Despite official 2018 GDP figures showing that the Chinese economy grew last year at its slowest pace in 28 years, some of China’s largest stocks continue to perform at market-leading levels, led by tech quartet Tencent, Baidu, Sina and Alibaba. According to the data released by Beijing on Monday, China recorded a GDP growth rate

The post China’s Stocks Are on Fire Despite Slowest GDP Growth in Nearly 30 Years appeared first on CCN

News – CCN

Sudden Selloff Hits Hong Kong Stocks: $4.77 Billion Vaporized

A number of stocks tanked sharply without warning earlier today on the Hong Kong equity market, which is the fourth largest in the world. The market rout left investors with no time to exit their positions, leaving them with losses amounting to as much as $ 4.77 billion in a matter of minutes. Share prices of

The post Sudden Selloff Hits Hong Kong Stocks: $ 4.77 Billion Vaporized appeared first on CCN

News – CCN

Investors Probably Didn’t Turn Their Backs on Tilray Cannabis Stocks Today

Tilray’s share price plummeted today on the expiry of its IPO lock-up period. But is the sell-off investors exiting cannabis stocks? Or, is it as simple as Tilray “insiders” cashing in their profits? Tilray’s stock lost 17.24% by the end of trading on the Nasdaq today, wiping out recent day’s gains. With its IPO, Tilray … Continued

The post Investors Probably Didn’t Turn Their Backs on Tilray Cannabis Stocks Today appeared first on CCN

News – CCN

Pharma Stocks Decline as House Democrats Investigate Drug Prices

Stock prices of twelve of the largest pharmaceutical companies in the USA have fallen sharply after the commencement of a Congressional investigation into prescription drug pricing practices. In a statement released yesterday, it was revealed that the House Oversight Committee chaired by Senator Elijah Cummings (D-Md) sent letters requesting information about their pricing strategies to AbbVie, Amgen,

The post Pharma Stocks Decline as House Democrats Investigate Drug Prices appeared first on CCN

News – CCN